Skip to content

Clinical trials

Phase 2 Influenza, Human trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Influenza, Human Phase: Phase 2 Country / region: United Kingdom Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20064
20075
20082
20094
20122
20132
20153
20161
20171
20222
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated2
Unknown status2
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi Pasteur, a Sanofi Company4
University of Oxford4
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)3
GlaxoSmithKline3
Novartis Vaccines3
Novartis2
Autoimmune Technologies, LLC1
Barinthus Biotherapeutics1
Biota Scientific Management Pty Ltd1
Crucell Holland BV1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Influenza, Human32
Orthomyxoviridae Infections4
Adenoviridae Infections1
Coronavirus Infections1
Influenza in Birds1
Paramyxoviridae Infections1
Pneumonia, Viral1
Virus Diseases1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.